ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 97 filers reported holding ALBIREO PHARMA INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $522,962 | -65.4% | 24,200 | -69.0% | 0.00% | -66.7% |
Q3 2022 | $1,512,000 | -70.1% | 78,100 | -54.0% | 0.01% | -70.0% |
Q1 2022 | $5,059,000 | +344.2% | 169,600 | +246.9% | 0.02% | +300.0% |
Q4 2021 | $1,139,000 | -75.4% | 48,890 | -72.1% | 0.01% | -83.3% |
Q2 2020 | $4,636,000 | -45.0% | 175,000 | -66.0% | 0.03% | -55.9% |
Q1 2020 | $8,431,000 | +56.4% | 515,000 | +142.9% | 0.07% | +142.9% |
Q4 2019 | $5,390,000 | +206.6% | 212,030 | +141.2% | 0.03% | +154.5% |
Q3 2019 | $1,758,000 | -67.3% | 87,906 | -47.4% | 0.01% | -60.7% |
Q2 2019 | $5,383,000 | -8.9% | 166,964 | -9.0% | 0.03% | +3.7% |
Q1 2019 | $5,910,000 | +1658.9% | 183,495 | +1239.4% | 0.03% | +1250.0% |
Q4 2018 | $336,000 | -91.4% | 13,700 | -92.7% | 0.00% | -88.2% |
Q3 2017 | $3,910,000 | +1121.9% | 186,640 | +1100.9% | 0.02% | +750.0% |
Q2 2017 | $320,000 | – | 15,542 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 1,704,330 | $60,504,000 | 1.59% |
Birchview Capital, LP | 38,000 | $1,349,000 | 0.92% |
Virtus ETF Advisers LLC | 24,688 | $876,000 | 0.77% |
BVF INC/IL | 220,000 | $7,810,000 | 0.76% |
SECTORAL ASSET MANAGEMENT INC | 172,803 | $6,135,000 | 0.69% |
Chicago Capital, LLC | 134,748 | $4,784,000 | 0.39% |
Artal Group S.A. | 500,000 | $17,750,000 | 0.38% |
TPG Group Holdings (SBS) Advisors, Inc. | 716,381 | $25,432,000 | 0.33% |
Eversept Partners, LP | 18,029 | $640,030 | 0.29% |
HEARTLAND ADVISORS INC | 125,000 | $4,438,000 | 0.29% |